This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Mitsubishi Tanabe Pharma Corporation. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Innovations by Hisashi Kawasumi in Pharmaceutical Development
Introduction
Hisashi Kawasumi is an accomplished inventor based in Osaka, Japan, renowned for his contributions to the pharmaceutical industry. His innovative approach has led to the development of significant inventions aimed at enhancing therapeutic options for various conditions. With a notable patent to his name, Kawasumi's work continues to impact the field of medicine.
Latest Patents
Hisashi Kawasumi holds a patent for a "Malonic acid sulfonamide derivative and pharmaceutical use thereof." This invention presents a sulfonyl malonamide derivative, or its pharmacologically acceptable salt or solvate. It demonstrates therapeutic and preventive effects on various diseases by acting as an agonist at the angiotensin II receptor. This innovation holds promise as a pharmaceutical agent for addressing diseases influenced by the renin-angiotensin-aldosterone system (RAAS).
Career Highlights
Currently affiliated with Mitsubishi Tanabe Pharma Corporation, Hisashi Kawasumi has made significant strides in drug development. His work focuses on creating treatments that leverage the body's own systems to combat various health issues, underscoring his dedication to advancing medical science.
Collaborations
Kawasumi has worked alongside esteemed colleagues such as Tomohiro Yoshida and Hiroshi Sakashita. These collaborations reflect a strong commitment to innovation within a team environment, fostering creativity and groundbreaking advancements in the pharmaceutical sector.
Conclusion
Hisashi Kawasumi's contributions to the field of pharmaceuticals through his inventive work exemplify the critical role of innovation in medicine. With a focus on enhancing therapeutic options, his patent work aims to address vital health challenges, paving the way for future breakthroughs in treatment and prevention strategies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
